These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18662913)

  • 21. Immunosuppression in corneal transplantation.
    Hill JC
    Eye (Lond); 1995; 9 ( Pt 2)():247-53. PubMed ID: 7556726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous dexamethasone vs methylprednisolone pulse therapy in the treatment of acute endothelial graft rejection.
    Tandon R; Verma K; Chawla B; Sharma N; Titiyal JS; Kalaivani M; Vajpayee RB
    Eye (Lond); 2009 Mar; 23(3):635-9. PubMed ID: 18292787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratoplasty postoperative treatment update.
    Shimmura-Tomita M; Shimmura S; Satake Y; Shimazaki-Den S; Omoto M; Tsubota K; Shimazaki J
    Cornea; 2013 Nov; 32 Suppl 1():S60-4. PubMed ID: 24104936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graft rejection and graft failure after penetrating keratoplasty or posterior lamellar keratoplasty for fuchs endothelial dystrophy.
    Hjortdal J; Pedersen IB; Bak-Nielsen S; Ivarsen A
    Cornea; 2013 May; 32(5):e60-3. PubMed ID: 23086366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study.
    Küchle M; Cursiefen C; Nguyen NX; Langenbucher A; Seitz B; Wenkel H; Martus P; Naumann GO
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):580-4. PubMed ID: 12136292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indications, outcomes, and risk factors for failure in tectonic keratoplasty.
    Ang M; Mehta JS; Sng CC; Htoon HM; Tan DT
    Ophthalmology; 2012 Jul; 119(7):1311-9. PubMed ID: 22541633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study.
    Magalhaes OA; Marinho DR; Kwitko S
    Br J Ophthalmol; 2013 Nov; 97(11):1395-8. PubMed ID: 24008822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rejection of corneal allografts].
    Guilbert E; Laroche L; Borderie V
    J Fr Ophtalmol; 2011 May; 34(5):331-48. PubMed ID: 21492957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial.
    Sinha R; Jhanji V; Verma K; Sharma N; Biswas NR; Vajpayee RB
    Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1167-72. PubMed ID: 20414783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clear graft survival and immune reactions following emergency keratoplasty.
    Maier P; Böhringer D; Reinhard T
    Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):351-9. PubMed ID: 17024439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cyclosporin A eyedrops in the prevention of high-risk corneal graft rejection. II. Postoperative clinical results].
    Goichot-Bonnat L; Chemla P; Pouliquen Y
    J Fr Ophtalmol; 1987; 10(3):213-7. PubMed ID: 3301994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical corticosteroids with topical cyclosporine A versus topical corticosteroids alone for immunological corneal graft rejection.
    Marques RE; Leal I; Guerra PS; Barão RC; Quintas AM; Rodrigues W
    Eur J Ophthalmol; 2022 May; 32(3):1469-1481. PubMed ID: 34231398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunological aspects of corneal graft rejection and own experience in immunosuppressive therapy in high risk patients].
    Kamińska A; Szaflik J; Minkiewicz-Timler G; Sybilska M; Pawluczyk-Dyjecińska M; Smolarek M
    Klin Oczna; 2004; 106(3 Suppl):485-8. PubMed ID: 15636244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation.
    Shimazaki J; Den S; Omoto M; Satake Y; Shimmura S; Tsubota K
    Am J Ophthalmol; 2011 Jul; 152(1):33-39.e1. PubMed ID: 21570054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical Cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial.
    Poon A; Constantinou M; Lamoureux E; Taylor HR
    Clin Exp Ophthalmol; 2008 Jul; 36(5):415-21. PubMed ID: 18939344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new model of corneal transplantation in the miniature pig: efficacy of immunosuppressive treatment.
    Tavandzi U; Procházka R; Usvald D; Hlucílová J; Vitásková M; Motlík J; Vítová A; Filipec M; Forrester JV; Holán V
    Transplantation; 2007 May; 83(10):1401-3. PubMed ID: 17519795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative outcomes of penetrating and component endothelial cell corneal allografts in outbred sheep.
    Mills RA; Klebe S; Coster DJ; Williams KA
    Cell Transplant; 2014 Jan; 23(1):133-8. PubMed ID: 23211557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
    Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical tacrolimus in high-risk corneal transplants.
    Bernardes L; Gil J; Costa E; Tavares C; Rosa A; Quadrado MJ; Murta J
    Eur J Ophthalmol; 2024 Jan; 34(1):140-145. PubMed ID: 37128645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical cyclosporine in corneal transplantation.
    Ziaei M; Manzouri B
    Cornea; 2015 Jan; 34(1):110-5. PubMed ID: 25357076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.